Introduction - SGLT2 inhibition in diabetes and heart failure: discuss the evidence.
Topic:
Diabetes management
Speaker:
Doctor D. Fitchett (Toronto, CA)
Organised by Academic Medical Center Amsterdam. Dept Vascular Medicine and Physicians' Academy for Cardiovascular Education / Course Director: Prof John Kastelein / Supported by an unrestricted educational grant from Boehringer Ingelheim/Lilly
Event:
ESC Congress 2016
Congress Presentation
About the speaker
Doctor David Fitchett
St. Michael's Hospital, Toronto (Canada)
18
presentations
0
follower
2 more presentations in this session
SGLT2 inhibition: exploring the evidence in diabetes and heart failure.
Speaker: Professor J. McMurray (Glasgow, GB)
Interactive discussion: what are the implications of SGLT2 inhibition in HF patients with diabetes?
Speaker: Doctor D. Fitchett (Toronto, CA) Professor J. McMurray (Glasgow, GB)
Access the full session
SGLT2 inhibition in diabetes and heart failure: discuss the evidence
Speakers:
Doctor D. Fitchett, Professor J. McMurray, Doctor D. Fitchett, Professor J. McMurray
About the event
ESC 365 is supported by
